Xiaoping Sun, M.D., Ph.D.
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1994 | Combined PhD Program of Catholic University of Nijmegen, Nijmegen, The Netherlands, and Shanghai Institute of Cell Biology, Chinese Academy of Sciences, Shanghai, CN, Ph.D. in Molecular Genetics |
| 1989 | Shanghai Institute of Cell Biology, Chinese Academy of Sciences, Shanghai, CN, M.S. in Molecular and Cellular Biology |
| 1984 | Zhejiang Medical University, Hangzhou, CN, MD |
Postgraduate Training
| 2007-2008 | Faculty Leadership Academy (54 hours), The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2005-2005 | The Heart of Leadership: Core Skill Program (16 hours), The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2002-2003 | Fellow, Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1998-2002 | Resident, Anatomical and Clinical Pathology, Department of Pathology, Northwestern University Medical School, Chicago, Illinois |
| 1994-1998 | Postdoctoral fellow and research associate, The Salk Institute for Biological Studies, La Jolla, California |
Licenses & Certifications
| 2003 | Hematology, The American Board of Pathology |
| 2003 | Not specified |
| 2002 | Anatomic Pathology and Clinical Pathology, The American Board of Pathology |
Experience & Service
Faculty Academic Appointments
Associate Professor, Laboratory Medicine, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2015
Assistant Professor, Laboratory Medicine, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2009
Administrative Appointments/Responsibilities
Cultural Principles Working Group, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2005 - 2010
General Laboratory Software Project Team, The University of Texas M. D. Anderson Cancer Center, Houston, 2005 - 2010
JCAHO Key Contact Physician, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2010
Other Professional Positions
Judge for Presentation Award, Texas Chapter, Society of Chinese Bioscientists in America, Houston, TX, 2016
Physician, internal medicine, Zhejiang Medical University, Hangzhou, 1984 - 1986
Extramural Institutional Committee Activities
elected member, PRS Budget & Finance Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Committee Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2011 - 2014
Member, The Center for Stem Cell and Developmental Biology, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Center for Biological Pathways, The University of Texas MD Anderson Cancer Center, 2010 - Present
Study Section, University of Texas M.D. Anderson Cancer Center Institutional Research Grant, The University of Texas MD Anderson Cancer Center, 2007 - 2010
Steering Committee Member, Hematopathology Tissue Bank, The University of Texas MD Anderson Cancer Center, 2003 - Present
Honors & Awards
| 2019 - 2021 | Member of the Year Award, Chinese American Pathologists Association (CAPA) |
| 2018 | Appreciation Award, Chinese American Pathologists Association (CAPA), 2018 |
| 2017 - Present | Member of the Year Award, Chinese American Pathologists Association CAPA |
| 2010 | American Cancer Society Research Scholar |
| 2005 | Physician Scientist Program Award, University of Texas M. D. Anderson Cancer Center |
| 2002 | Fellow Research Award, Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center |
| 2001 | Goldberg Family Charitable Trust (GFCT) Travel Award, Northwestern Memorial Hospital, Chicago, Illinois |
| 1996 - 1998 | Research Postdoctoral Fellowship Award, National Institute of Health, USA |
| 1993 - 1994 | Research Fellowship Award, Max-Plank-Gesellschaft, Germany |
| 1991 - 1993 | Research Fellowship Award, Deutsche Forschungsgemeinschaft, Germany |
| 1990 - 1991 | Research Scholarship Award, Koninklijke Nederlandse Akademic van Wetenschappen, The Netherlands |
| 1984 | National Medical Examination Award, Health Department of P. R. China |
| 1979 - 1984 | Honors Student (top 5%), yearly, Zhejiang Medical University |
Professional Memberships
Selected Presentations & Talks
Formal Peers
- 2019. Circulating Tumor Cells, the basics and clinical application. Visiting, US.
- 2019. “Circulating Tumor Cells, the basics and clinical application. Visiting, US.
- 2018. “Circulating Tumor Cells, the basics and clinical application”. Visiting, US.
- 2016. “Training of Medical Doctors in USA”. Invited. Xinjiang, CN.
- 2016. “Comparison of Medical Practice in USA and China”. Visiting. Tianjin, CN.
- 2015. “Role of Sox4 in early B-cell development”. Invited. Beijing, CN.
- 2014. "A novel type of drug resistance: imatinib-induced MSC-mediated drug resistance in BCR-ABL+acute lymphoblastic leukemia". Invited. Hangzhou, CN.
- 2014. "The Phenotype and Molecular Mechanisms of Sox4 in Benign and Malignant B Cells". Invited. Chicago, IL, US.
- 2010. "The role of Sox4 in early B cell development and acute lymphoblastic leukemia". Invited. Hangzhou, Hangzhou, CN.
- 2008. "Interesting Cases of Benign Hematological Diseases". Invited. Stony Brook, NY, US.
- 2008. "Leukemias and their molecular markers". Invited. Stony Brook, NY, US.
- 2008. "Castleman Disease and Follicular Dendritic Cell Sarcoma, Connections and Pathways". Invited. Long Island, NY, US.
- 2006. "Current Status of USA Physicians". Invited. Hangzhou, CN.
- 2006. "Medical Practice in USA". Invited. Linhai, CN.
- 2006. "Patient Care, Research, and Education at M.D. Anderson Cancer Center". Invited. Beijing, CN.
- 2006. "Current status of USA Physicians". Invited. Beijing, CN.
- 2004. "Medical/Pathology Practice in USA". Invited. Hangzhou, CN.
- 2004. "Microscopic conference on difficult/interesting hematology cases". Invited. Hangzhou, CN.
Grant & Contract Support
| Date: | 2014 - 2017 |
| Title: | "Study Sox4 regulated genes in B cell development in a novel in vitro system" |
| Funding Source: | NIH/NIAID |
| Role: | PI |
| ID: | 1R21AI103652-01A1 |
| Date: | 2014 - 2017 |
| Title: | "Target both BCR-ABL and MSC-mediated signaling in BCR-ABL + ALL" |
| Funding Source: | MDACC IRG |
| Role: | PI |
| Date: | 2013 - 2018 |
| Title: | Developmental Research Award |
| Funding Source: | MDACC Leukemic SPORE |
| Role: | PI |
| Date: | 2010 - 2012 |
| Title: | "Sox4 in breast cancer metastasis" |
| Funding Source: | MDACC IRG |
| Role: | Collaborator |
| Date: | 2010 - 2015 |
| Title: | "Role of Sox4 in the interaction between leukemic cells and their niches" |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| ID: | RSG-10-131-01-DDC |
| Date: | 2010 - 2012 |
| Title: | "Role of Sox4 in B Cell Development" |
| Funding Source: | NIAID/NIH |
| Role: | PI |
| ID: | 1-R03-AI079779-01-A1 |
| Date: | 2009 - 2011 |
| Title: | "SOX4 in B lymphopoiesis" |
| Funding Source: | MDACC IRG |
| Role: | PI |
| Date: | 2009 - 2010 |
| Title: | “Uprooting Leukemic Cells by Targeting SOX4” |
| Funding Source: | The Ladies Leukemia League |
| Role: | PI |
| Date: | 2009 - 2010 |
| Title: | “Mouse Models to Study the Role of SOX4 in Leukemia” |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| Date: | 2005 - 2013 |
| Title: | "Role of Sox4 in Human Leukemia". Physician Scientist Program Award |
| Funding Source: | University of Texas M. D. Anderson Cancer Center |
| Role: | PI |
| Date: | 2005 - 2006 |
| Title: | "Role of the SOX4 Gene in Human Leukemia" |
| Funding Source: | MDACC IRG |
| Role: | PI |
| Date: | 2003 - Present |
| Title: | New Faculty Start-up Fund |
| Funding Source: | University of Texas M. D. Anderson Cancer Center |
| Role: | PI |
| Title: | "Role of Sox4 in Acute Lymphoblastic Leukemia" |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | "Role of Sox4 in B Cell Development". R21 |
| Funding Source: | NIH |
| Role: | PI |
| Title: | "Dissociate leukemic cells from their niches by targeting SOX4 to sensitize leukemic cells to chemotherapy" |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | "Targeting SOX4 Pathway To Disrupt the Interaction Between Cancer Cells and Stromal Cells To Prevent Breast Cancer Metastasis". Leukemia Research Foundation |
| Funding Source: | Leukemia Research Foundation |
| Role: | PI |
| Title: | "Targeting mesenchymal stem cells with p38 MAPK inhibitors to overcome leukemic cell resistance to tyrosine kinase inhibitors in BCR-ABL+ acute lymphoblastic leukemia". CPRIT |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | "Targeting SOX4 and its Pathway to Prevent Breast Cancer Micrometastasis and Macrometastasis" |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| Title: | "Role of Sox4 in the interaction between developing B cells and their niches". R01 |
| Funding Source: | NIH/NIAID |
| Role: | PI |
| Title: | "Target both BCR ABL and MSC mediated signaling in BCR ABL ALL" |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | "Role of SOX4 in Human Leukemia". K08 |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | "A novel therapeutic strategy to overcome drug resistance in BCR-ABL+ ALL". Rally and Bear Necessities |
| Funding Source: | Rally and Bear Necessities |
| Role: | PI |
| Title: | "Develop a novel therapeutic strategy to effectively overcome drug resistance in BCR-ABL+ acute lymphoblastic leukemia". R01 |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | “Uprooting Leukemic Cells by Targeting SOX4”. New Investigator Grant |
| Funding Source: | Leukemia Research Foundation |
| Role: | PI |
| Title: | "Targeting SOX4 Pathway to Disrupt the Interaction between Cancer Cells and Stromal Cells To Prevent Breast Cancer Metastasis". Investigator Initiated Research Award |
| Funding Source: | DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
| Role: | PI |
| Title: | "Eliminate imatinib-induced MSC-mediated drug resistance" |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | "Role of Sox4 in early B Cell Development". R01 |
| Funding Source: | NIH |
| Role: | PI |
| Title: | "Role of Sox4 in regulating Wnt/Beta-catenin signaling in B cell development". R01 |
| Funding Source: | NIH/NIAID |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Hu Z, Shi A, Liu J, Han X, Wang W, Hu S, Shuai W, Wang S, You MJ, Sun X, Hansel D, Hirsch-Ginsberg C, Chen L, Xie W. Artificial Intelligence-Enhanced Image Analysis of Peripheral Blood Smears Aids in the Diagnosis and Follow-Up of Acute Promyelocytic Leukemia 105(3). e-Pub 2025.
- Xu-Monette, Z, Wei, L, Fang, X, Au, Q, Nunns, H, Nagy, M, Tzankov, A, Zhu, F, Visco, C, Bhagat, G, Dybkær, K, Chiu, A, Tam, W, Zu, Y, Hsi, ED, Hagemeister, FB, Sun, X, Han, X, Go, H, Ponzoni, M, Ferreri, AJ, Møller, MB, Parsons, BM, Van Krieken, JH, Piris, MA, Winter, JN, Li, Y, Xu, B, Albitar, M, You, H, Young, KH. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical Cancer Research 28(5):972-983, 2022. e-Pub 2022. PMID: 34980601.
- Xia, M, Wu, L, Sun, X, Han, X, Yan, H, Huang, J, Zhang, Y, Hu, Z, Zu, Y, Yin, CC, Qiu, X. Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia. Biology 11(2), 2022. e-Pub 2022. PMID: 35205028.
- Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong Y. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol 152(4):495-501, 2019. e-Pub 2019. PMID: 31175351.
- Mallampati S, Duose DY, Harmon MA, Mehrotra M, Kanagal-Shamanna R, Zalles S, Wistuba II, Sun X, Luthra R. Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic Malignancies. J Mol Diagn 21(3):471-482, 2019. e-Pub 2019. PMID: 30794984.
- He J, Huo L, Ma J, Zhao J, Bassett RL, Sun X, Ueno NT, Lim B, Gong Y. Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications. Am J Clin Pathol 149(3):253-261, 2018. e-Pub 2018. PMID: 29425258.
- Huang X, Cao M, Wu S, Wang L, Hu J, Mehran RJ, Roth JA, Swisher SG, Wang RY, Kantarjian HM, Andreeff M, Sun X, Fang B. Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities. Oncotarget 8(60):102150-102160, 2017. e-Pub 2017. PMID: 29254232.
- Mu C, Wu X, Ma H, Tao W, Zhang G, Xia X, Shen J, Mai J, Sun T, Sun X, Arlinghaus RB, Shen H. Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia. Mol Cancer Ther 15(5):899-910, 2016. e-Pub 2016. PMID: 26846820.
- Chakraborty S, Leng, Xiaohong, Perazzona B, Sun X, Lin YH, Arlinghaus RB. Combination of Jak2 and HSP90 inhibitors: an effective therapeutic option in chronic myelogenous leukemia. Genes & Cancer 7(5-6):201-8, 2016. e-Pub 2016.
- Liu H, Sun X. Pleomorphic plasma cell leukemia. Blood 126(21):2436, 2015. e-Pub 2015. PMID: 26904765.
- Yang L, Zhang S, George SK, Teng R, You X, Xu M, Liu H, Sun X, Amin HM, Shi W. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget 6(17):14953-69, 2015. e-Pub 2015. PMID: 25879451.
- Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, Lin K, Lu Y, Yang Y, Sun B, Gong Y, Lee JS, Konopleva M, Andreeff M, Arlinghaus RB, Cai Z, Fang B, Shen H, Han X, Hirsch-Ginsberg CF, Gao X, Paranjape AN, Mani SA, Clise-Dwyer K, Sun X. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL acute lymphoblastic leukemia. Blood 125(19):2968-73, 2015. e-Pub 2015. PMID: 25712988.
- Huang X, Cao M, Wang L, Wu S, Liu X, Li H, Zhang H, Wang RY, Sun X, Wei C, Baggerly KA, Roth JA, Wang M, Swisher SG, Fang B. Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380. Oncotarget 6(1):345-54, 2015. e-Pub 2015. PMID: 25514600.
- Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC. IGK with conserved IGKV/IGKJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration. Oncotarget 6(37):29062-72, 2015. e-Pub 2015.
- Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang B. Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorg Med Chem 22(19):5234-40, 2014. e-Pub 2014. PMID: 25182964.
- Mallampati S, Sun B, Lu Y, Ma H, Gong Y, Wang D, Lee JS, Lin K, Sun X. Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1ε. Blood 123(26):4064-76, 2014. e-Pub 2014. PMID: 24786772.
- Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, Arlinghaus RB, Glassman A, Sun X. Sox4/Tcf7l1 Axis Is Essential for Initiation and Progression of p190 BCR-ABL+ Acute Lymphoblastic Leukemia. Haematologica 99(10):1591-1598, 2014. e-Pub 2014.
- Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC. IGK with conserved IGKV/IGKJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration 6(36):29062-72, 2014. e-Pub 2014.
- Ma H, Sun H, Sun X. Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep 4:4227, 2014. e-Pub 2014. PMID: 24572378.
- Zhang YH, Liu J, Dawlett M, Guo M, Sun X, Gong Y. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Cancer Cytopathol 122(12):892-7, 2014. e-Pub 2014. PMID: 25056830.
- Huang J, Sun X, Gong X, He Z, Chen L, Qiu X, Yin CC. Rearrangement and expression of immunoglobulin μ chain gene in human myeloid cells. Cellular & Molecular Immunology 11:94-104, 2014. e-Pub 2014.
- Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Sox4 is required for the survival of pro-B cells. J Immunol 190(5):2080-9, 2013. e-Pub 2013. PMID: 23345330.
- Yang Y, Mallampati S, Sun B, Zhang J, Gong Y, Cai Z, Sun X. Protection of ALL Cells by Bone Marrow Stromal Cells and the Underlying Molecular Mechanism. Cancer Letters 333:9-17, 2013. e-Pub 2013.
- Qui X, Sun X, He Z, Huang J, Hu F, Chen L, Lin P, You J, Medeiros J, and Yin C. Immunoglobulin gamma chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia. Leukemia 27:92-9, 2013. e-Pub 2013.
- Lin S, Tian L, Shen H, Gu Y, Li JL, Chen Z, Sun X, James You M, Wu L. DDX5 is a positive regulator of oncogenic NPTCH1 signaling in T cell acute lymphoblastic leukemia. Oncogene. e-Pub 2012.
- Zhang J, Li GL, Li ZQ, Yi Z, Jin KT, Wang HH, Gong Y, Sun X, Cao J, and Deng LS. Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Steroids 77(6):666-73, 2012. e-Pub 2012.
- Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117(24):5476-84, 2011. e-Pub 2011. PMID: 21713757.
- Samanta A, Perazzona B, Chakraborty S, Sun X, Modi H, Bhatia R, Priebe W, Arlinghaus R. Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia 25:464-472, 2011. e-Pub 2011.
- Shi P, Chandra J, Sun X, Gergely M, Cortes JE, Garcia-Manero G, Arlinghaus RB, Lai R, Amin HM. Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells. J Cell Mol Med 14(6B):1777-92, 2010. e-Pub 2010. PMID: 19508387.
- Samanta AK, Chakraborty, SN, Wang, Y, Kantarjian H, Sun X, Hood J, Perrotti D, Arlinghaus RB. Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene 28:1669-81, 2009. e-Pub 2009. PMID: 19234487.
- Yu Z, Sun B, Kantarjian HM, Keating MJ, Amin HM, Sun X. Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators. Leuk Lymphoma 49(4):751-6, 2008. e-Pub 2008. PMID: 18398743.
- Sun X, Zhang W, Ramdas L, Stivers DN, Jones DM, Kantarjian HM, Estey EH, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE. Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping. Mod Pathol 20(8):811-20, 2007. e-Pub 2007. PMID: 17571080.
- Gong Y, Sun X. Fine needle analysis of a presacral myelolipoma. Diagn Cytopathol 34:29-30, 2006. e-Pub 2006. PMID: 16355397.
- Gong Y, Ren R, Ordonez NG, Sun X, Sneige N. Fine needle aspiration cytology of well-differentiated papillary mesothelioma. Acta Cytol 49:537-42, 2005. e-Pub 2005. PMID: 16334033.
- Gong Y, Sun X, Huo L, Wiley EL, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology 46:1-7, 2005. e-Pub 2005. PMID: 15656882.
- Sun X, Amin HM, Freireich EJ, Keating MJ, Kantarjian HM, Koller CA, O’Brien SM, Giles F, Albitar M. Hairy Cell Leukemia with Large Cells: Long Disease Course with Adequate Response to Therapy. Leukemia 18:1912-14, 2004. e-Pub 2004.
- Sun X, Peterson LC, Gong Y, Traynor AE, Nelson BP. Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients. Mod Pathol 17:389-394, 2004. e-Pub 2004.
- Ren R, Sun X, Staerkel G, Gong Y. Fine-needle aspiration cytology of a liver metastasis of follicular dendritic cell sarcoma. Diagnostic Cytopathology 32:38-43, 2004. e-Pub 2004.
- Kidwai N, Gong Y, Sun X, Deshpande CG, Yeldandi AV, Rao MS, Badve S. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Research 6:R18-23, 2004. e-Pub 2004.
- Gong Y, Caraway N, Gu J, Zaidi T, Fernandez R, Sun X, Huh YO, Katz RL. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates. Cancer 99:385-93, 2003. e-Pub 2003. PMID: 14681948.
- Sun X, Gong Y, Pins M. Paratesticular mass in a 50-year-old man. Archives of Pathology & Laboratory Medicine 127:e111-112, 2003. e-Pub 2003.
- Sun X, Le HD, Wahlstrom JM, Karpen GH. Sequence analysis of a functional Drosophila centromere. Genome Research 13:182-184, 2003. e-Pub 2003.
- Sun X, Medeiros LJ, Hu QL, Lu D, Bueso-Ramos C. Prominent dysplasia and high proliferation rate are common in acute myeloid leukemia with inv(16)(p13q22). Am J Clin Pathol 120:236-45, 2003. e-Pub 2003. PMID: 12931554.
- Sun X, Chang KC, Abruzzo LV, Lai R, Younes A, Jones D. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease. Hum Pathol 34:835-40, 2003. e-Pub 2003. PMID: 14562277.
- Gong Y, Sun X, Haines K, Pins M. Renal cell carcinoma, chromophobe type, with collecting duct carcinoma and sarcomatoid components. Archives of Pathology & Laboratory Medicine 127:e38-40, 2003. e-Pub 2003.
- Adley BP, Sun X, Shaw JM, Variakojis D. Hairy cell leukemia with marked lymphocytosis. Archives of Pathology & Laboratory Medicine 127:253-254, 2003. e-Pub 2003.
- Gong Y, Sun X, Michael CW, Attal S, Williamson B, Bedrossian CWM. Immunocytochemistry on serous effusion specimens: a comparison of ThinPrep versus cell block. Diagnostic Cytopathology 28:1-5, 2003. e-Pub 2003.
- Sun X, Gong Y, Rao S, Badve S. Loss of BRCA1 expression in sporadic male breast carcinoma. Breast Cancer Research and Treatment 71:1-7, 2002. e-Pub 2002.
- Sun X, Gong Y, Talamonti MS, Rao S. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Modern Pathology 15:1333-1338, 2002. e-Pub 2002.
- Gong Y, Chao J, Bauer B, Sun X, Chou PM. Primary cutaneous alveolar rhabdomyosarcoma of perineum. Archives of Pathology & Laboratory Medicine 126:982-984, 2002. e-Pub 2002.
- Sun X, Gordon LI, Peterson LC. Transformation of follicular lymphoma to acute lymphoblastic leukemia. Archives of Pathology & Laboratory Medicine 126:997-998, 2002. e-Pub 2002.
- Lin G, Sun X, Badve S. Vaginal wall mass in a 47-year-old woman. Archives of Pathology & Laboratory Medicine 126:1241-42, 2002. e-Pub 2002.
- Harhangi HR, Sun X, Wang YX, Akhmanova A, Miedema K, Heyting C, Hennig W. RADHA-a new male germ line-specific chromosomal protein of Drosophila. Chromosoma 108:235-242, 1999. e-Pub 1999.
- Sun X, Wahlstrom J, Karpen G. Molecular structure of a functional Drosophila centromere. Cell 91:1007-1019, 1997. e-Pub 1997. PMID: 9428523.
- Sun X. Progress in studies of Drosophila spermatogenesis. Journal of Cell Biology (Chinese) 14:1-7, 1992. e-Pub 1992.
- Zhu J, Sun X, Wang, F. The DNA intercalator, ethidium bromide, alters the pattern of DNAse I hypersensitive sites of the B-globin gene in chicken erythrocytes. Biochimica et Biophysica Acta 1089:158-166, 1991. e-Pub 1991. PMID: 2054379.
- Lin S, Sun X, Li C, Ma Y, Zhao Z. Effects of b-lactamase inhibitors on bacterial ampicillin resistance. Zhejiang Medicine (Chinese) 112:22-31, 1986. e-Pub 1986.
- Mallampati S, Zeng J, Li J, Patchva S, Vijay GV, Gong Y, Konopleva M, Fang B, Shen H, Han X, Hirsch-Ginsberg CF, Hawke DH, Clise-Dwyer K, Mani SA, Sun X. p38 MAPK inhibitors prevent mesenchymal stem cell–mediated tyrosine kinase inhibitor resistance in BCR-ABL+ ALL. Blood.
Other Articles
- Kim, DH, Sun, X ALK-positive anaplastic large cell lymphoma that presented as pleural effusion. Blood Research 57(1):5, 2022. PMID: 35342041.
Abstracts
- Hou T, Gan Q, Joseph C, Sun X, Gong Y. Insulinoma-associated Protein 1 (INSM1) Immunostaining in Various Types of Neuroendocrine Tumors on Fine-Needle Aspiration Smear, 2020. e-Pub 2020.
- Gan Q, Joseph CT, Guo M, Sun X, Gong Y. NKX3.1 is a Sensitive Marker for Detecting Metastic Prostatic Carcinoma Except for Small Cell Variant on Fine-Needle Aspiration Smears. Poster presentation at the ASC's 66th Annual Scientific Meeting, 2018. e-Pub 2018.
- Mallampati S, Zeng J, Li J, Sun X. Targeting IL-7/IL-7R pathway to overcome TKI-induced MSC-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. International Journal of Molecular Medicine 36:supplement, 2015. e-Pub 2015.
- Harutyunyan KG, Nwajei F, Zal MA, Fruman DA, Mallampati S, Sun X, Zal T, Konopleva M. The Dynamics of Stroma-Leukemia Interaction in the Hypoxic BM Niches in Vivo. Blood 124:2396, 2014. e-Pub 2014.
- Zhang YH, Liu J, Dawlett M, Guo M, Sun X, Gong Y. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Modern Pathology, 2014. e-Pub 2014.
- Ma H, Mallampati S, Sun B, Gong Y, Lefebvre V, and Sun X. Sox4 is Essential for Initiation and Progression of Acute Lymphoblastic Leukemia Induced by P190-BCR-ABL Transformation. The 53rd American Society of Hematology Annual Meeting. Blood 118(21):260 (#564), 2011. e-Pub 2011.
- Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, and Sun X. Conditional Knockout of Sox4 Markedly Affects Early B Lymphopoiesis in Adult Mice. The 53rd American Society of Hematology Annual Meeting. Blood 118(21):417 (#913), 2011. e-Pub 2011.
- Samanta AK, Perazzona B, Chakraborty SN, Sun X, Modi H, Bhatia R, Arlinghaus RB. Jak2 Regulates Bcr-Abl In CD34+ Cells From Imatinib Mesylate-Resistant CML Patient. The 52nd American Society of Hematology Annual Meeting. Blood 116(21):522 (#1220), 2010. e-Pub 2010.
- Yang Y, Sun B, Mallampati S, Cai Z, and Sun X. Protection of ALL Cells by Bone Marrow Stromal Cells and the Underlying Molecular Mechanism. The 52nd American Society of Hematology Annual Meeting. Blood 116(21):1070 (#2587), 2010. e-Pub 2010.
- Dai A, Zhao C, Yin, CC, Chen L, Sun X, Dave S, Huang X, Zhang YH, Han X, You MJ. Hypermethylation of DBCCR1 Gene in Acute Myeloid Leukemia. Poster presentation at the 2010 AACR Annual Meeting in Washington, DC, 2010. e-Pub 2010.
- Qiu X, Sun X, He Z, Lin P, You MJ, Chen L, Dai C, Yin CC. Expression of immunoglobulin gene in myeloblasts from patients with acute myelogenous leukemia and its distinct VKJK recombination pattern. Poster presentation at the 2010 AACR Annual Meeting in Washington, DC, 2010. e-Pub 2010.
- Sun B, Mallampati S, Gong Y, Wang D, You MJ, Amin HM, Ma Y, Rajewsky K, Lefebvre V, and Sun X. Conditional Knockout of Sox4 Markedly Affects B Lymphopoiesis in Adult Mice. The 51st American Society of Hematology Annual Meeting. Blood 114(22):994 (#2524), 2009. e-Pub 2009.
- Qiu X, Lin P, Sun X, You J, Medeiros LJ, Yin CC. Detection of Mono/Oligo Clonal IgH Gene Rearrangements and Characterization of Associated Clinicopathologic Features in Acute Myeloid Leukemia. Modern Pathology 22(suppl):281, 2009. e-Pub 2009.
- Gan Q, Joseph C, Sun X, Gong Y. NKX3.1 is a Sensitive Marker for Detecting Metastatic Prostatic Carcinoma Except for Small Cell Variant on Fine-Needle Aspiration Smears. Journal of the American Society of Cytopathology 7(5):S39-40.
- Liu JM, Gong Y, Sun X, Shi A,, Han X, Liu J, Wang P, Subash KM, Wang JW, Chen HG, Medeiros LJ, Wang W, Wu J, Hu Z. Quantitative assessment of Disease Status in Chronic Lymphocytic Leukemia Using Artificial Intelligence (AI)-Assisted Peripheral Blood Smear Image Analysis. United States and Canadian Academy of Pathology’s 114th Annual Meeting.
- Liu Z, Castillo S.P., Han X, Sun X, Hu Z, Yuan Y. Enhancing White Blood Cell Classification through AI Analysis of CellaVision Images in Monocytosis Cases. USCAP 2024 Annual Meeting.
- Shi A, Liu JM, Wang W, Chen L, Medeiros LJ, Shuai W, Wang SA, You MJ, Hansel DH, Borthakur G, Hirsch-Ginsberg C, Hu S, Sun X, Hu Z. Artificial Intelligence-Assisted Image Analysis of Peripheral Blood Smears to Aid in the Diagnosis and Monitoring of Acute Promyelocytic Leukemia. United States and Canadian Academy of Pathology’s 114th Annual Meeting.
Letters to the Editor
- Hu, Z, Yin, CC, Sun, X, Han, X, Wang, W, Wang, S, You, MJ. A diagnostic dilemma for a patient with skin lesions and marked leukocytosis. Pathology 57: 371-374, 2025.
Patents
- Fractal Genomics Modeling (FGM) of AML with Inv(16)(p13q22)(M4Eo) and AML-M4. Patent Number: MDA05-053.
Patient Reviews
CV information above last modified July 22, 2026